Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers
Clinical trial NCT03237416 · COMPLETED
Trial details
- NCT number
- NCT03237416
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2017-10-05
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.